Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases
Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases: A Pilot Study
Sponsors |
Lead Sponsor: Xiangya Hospital of Central South University |
---|---|
Source | Xiangya Hospital of Central South University |
Brief Summary | Piezoelectric drived microneedling treats refractory skin disorders using hollow microneedles assisted by ultrasound. Mechanically, the injection of medicine by hollow microneedling could makes the distribution of medicine more evenly. And the addition of ultrasound technique improves the effectiveness of microneedling. Investigators plan to conduct a pilot study to investigate the efficacy of using piezoelectric drived microneedles in treating refractory skin diseases. |
Detailed Description | Piezoelectric drived microneedling treats refractory skin disorders using hollow microneedles assisted by ultrasound. Mechanically, the injection of medicine by hollow microneedling could makes the distribution of medicine more evenly. And the addition of ultrasound technique improves the effectiveness of microneedling. Investigators plan to conduct a pilot study to investigate the efficacy of using piezoelectric drived microneedles in treating refractory skin diseases. Investigators accept participants of hypertrophic scar, keloid and warts. For participants who are not candidates for traditional surgery, investigators will consider to accept carefully. |
||||||
---|---|---|---|---|---|---|---|
Overall Status | Recruiting | ||||||
Start Date | 2022-07-30 | ||||||
Completion Date | 2024-07-31 | ||||||
Primary Completion Date | 2024-06-30 | ||||||
Phase | N/A | ||||||
Study Type | Interventional | ||||||
Primary Outcome |
|
||||||
Secondary Outcome |
|
||||||
Enrollment | 20 |
Condition | |
---|---|
Intervention |
Intervention Type: Drug Intervention Name: Triamcinolone acetonide(scar)/5-ALA(others) Description: For scar, the drug is triamcinolone acetonide. Arm Group Label: Traditional injection Other Name: Intralesional drug delivery Intervention Type: Procedure Intervention Name: Piezoelectric drived microneedling Description: Piezoelectric drived microneedling Arm Group Label: Piezoelectric drived microneedling Intervention Type: Drug Intervention Name: 5-ALA (a photosensitizer for photodynamic therapy). Description: For other diseases, the drug is 5-ALA (a photosensitizer for photodynamic therapy). Arm Group Label: Piezoelectric drived microneedling |
Eligibility |
Criteria:
Inclusion Criteria: - Age over 16 years - Diagnosed by 2 or more professional dermatologists - Willing to underwent a new treatment modality - Follow up is easy to conduct Exclusion Criteria: - Poor general condition - Bleeding tendency - Allergy to drug Gender: All Minimum Age: 16 Years Maximum Age: N/A Healthy Volunteers: Accepts Healthy Volunteers |
Overall Contact | Contact information is only displayed when the study is recruiting subjects. | |||||
---|---|---|---|---|---|---|
Location |
|
Location Countries |
China |
---|---|
Verification Date |
2022-07-01 |
Responsible Party |
Type: Sponsor |
Keywords | |
Has Expanded Access | No |
Condition Browse | |
Number Of Arms | 2 |
Arm Group |
Label: Traditional injection Type: Active Comparator Description: Intralesional injection of drug by traditional injection needle. This is the traditional approach for drug delivery recommended by international guidelines for each skin diseases. Label: Piezoelectric drived microneedling Type: Experimental Description: Intralesional injection of drug by piezoelectric drived microneedles. |
Patient Data | No |
Study Design Info |
Allocation: Randomized Intervention Model: Parallel Assignment Intervention Model Description: Comparison is designed in each participant. For each individual, two similar hypertrophic scar/keloid or a single hypertrophic scar/keloid is randomly assigned into traditional injection group or piezoelectric divied microneedling group. Primary Purpose: Treatment Masking: Single (Outcomes Assessor) |
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Diseases
-
NCT05276661CompletedConditions: Skin Diseases
-
NCT02377557CompletedConditions: Skin Diseases
-
NCT04636164RecruitingConditions: Skin Diseases
-
NCT03963765CompletedConditions: Skin Diseases
-
NCT04254601CompletedConditions: Skin Diseases
-
NCT00541931CompletedConditions: Skin Diseases
-
NCT00162747CompletedConditions: Skin Diseases
-
NCT00186563CompletedConditions: Skin Diseases
-
NCT01865032CompletedConditions: Skin Diseases
-
NCT01975038CompletedConditions: Skin Diseases
Clinical Trials on Triamcinolone acetonide(scar)/5-ALA(others)
-
NCT05488860RecruitingConditions: Skin Diseases, Hypertrophic Scar, Keloid, Plantar Wart, Warts, Skin Tumor